Forewarning of hypotensive events using a Bayesian artificial neural network in neurocritical care.
Adolescent
Adult
Aged
Aged, 80 and over
Area Under Curve
Bayes Theorem
Brain Injuries
/ complications
Brain Injuries, Traumatic
Critical Care
/ methods
Databases, Factual
Diagnosis, Computer-Assisted
False Positive Reactions
Female
Humans
Hypotension
/ diagnosis
Intensive Care Units
Machine Learning
Male
Middle Aged
Neural Networks, Computer
Pilot Projects
Prospective Studies
Sample Size
Sensitivity and Specificity
Signal Processing, Computer-Assisted
Software
Young Adult
Bayesian prediction
Clinical study results
Neuro-intensive care
Traumatic brain injury
Journal
Journal of clinical monitoring and computing
ISSN: 1573-2614
Titre abrégé: J Clin Monit Comput
Pays: Netherlands
ID NLM: 9806357
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
22
07
2017
accepted:
14
03
2018
pubmed:
26
5
2018
medline:
6
8
2019
entrez:
26
5
2018
Statut:
ppublish
Résumé
Traumatically brain injured (TBI) patients are at risk from secondary insults. Arterial hypotension, critically low blood pressure, is one of the most dangerous secondary insults and is related to poor outcome in patients. The overall aim of this study was to get proof of the concept that advanced statistical techniques (machine learning) are methods that are able to provide early warning of impending hypotensive events before they occur during neuro-critical care. A Bayesian artificial neural network (BANN) model predicting episodes of hypotension was developed using data from 104 patients selected from the BrainIT multi-center database. Arterial hypotension events were recorded and defined using the Edinburgh University Secondary Insult Grades (EUSIG) physiological adverse event scoring system. The BANN was trained on a random selection of 50% of the available patients (n = 52) and validated on the remaining cohort. A multi-center prospective pilot study (Phase 1, n = 30) was then conducted with the system running live in the clinical environment, followed by a second validation pilot study (Phase 2, n = 49). From these prospectively collected data, a final evaluation study was done on 69 of these patients with 10 patients excluded from the Phase 2 study because of insufficient or invalid data. Each data collection phase was a prospective non-interventional observational study conducted in a live clinical setting to test the data collection systems and the model performance. No prediction information was available to the clinical teams during a patient's stay in the ICU. The final cohort (n = 69), using a decision threshold of 0.4, and including false positive checks, gave a sensitivity of 39.3% (95% CI 32.9-46.1) and a specificity of 91.5% (95% CI 89.0-93.7). Using a decision threshold of 0.3, and false positive correction, gave a sensitivity of 46.6% (95% CI 40.1-53.2) and specificity of 85.6% (95% CI 82.3-88.8). With a decision threshold of 0.3, > 15 min warning of patient instability can be achieved. We have shown, using advanced machine learning techniques running in a live neuro-critical care environment, that it would be possible to give neurointensive teams early warning of potential hypotensive events before they emerge, allowing closer monitoring and earlier clinical assessment in an attempt to prevent the onset of hypotension. The multi-centre clinical infrastructure developed to support the clinical studies provides a solid base for further collaborative research on data quality, false positive correction and the display of early warning data in a clinical setting.
Identifiants
pubmed: 29799079
doi: 10.1007/s10877-018-0139-y
pii: 10.1007/s10877-018-0139-y
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Pagination
39-51Subventions
Organisme : Medical Research Council
ID : MR/R004498/1
Pays : United Kingdom
Organisme : FP7 Research for the Benefit of SMEs
ID : IST-2007-217049
Investigateurs
John Pickard
(J)
Ian Whittle
(I)
None Dunn
Bertil Rydenhag
(B)
Stefan Iencean
(S)
None Pavalkis
None Meixensberger
Jan Goffin
(J)
Peter Vajkoczy
(P)
Nino Stocchetti
(N)
Della Corte
(D)
None Hell
Luciana Mascia
(L)
None Jarzemaskas
Reto Stocker
(R)
I R Chambers
(IR)
Giuseppe Citerio
(G)
Per Enblad
(P)
B A Gregson
(BA)
T Howells
(T)
Karl Kiening
(K)
J Mattern
(J)
P Nilsson
(P)
I Piper
(I)
Arminas Ragauskas
(A)
Juan Sahuquillo
(J)
Y H Yau
(YH)
Iain Chambers
(I)
David Wyper
(D)
Michael Kiefer
(M)
Dirk de Jong
(D)
Flemming Gjerris
(F)
Sue Hill
(S)
Garth Cruickshank
(G)
Lawrence Watkins
(L)
Références
Control Clin Trials. 1999 Dec;20(6):555-66
pubmed: 10588296
Nephrol Dial Transplant. 2004 May;19(5):1204-11
pubmed: 14993478
Anesthesiology. 2005 Jun;102(6):1079-80
pubmed: 15915015
Crit Care Med. 2005 Jun;33(6):1266-71
pubmed: 15942342
Anesth Analg. 2005 Sep;101(3):622-8, table of contents
pubmed: 16115962
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
Philos Trans A Math Phys Eng Sci. 2009 Jul 13;367(1898):2679-90
pubmed: 19487204
Anesthesiology. 2009 Dec;111(6):1217-26
pubmed: 19934864
Acta Neurochir (Wien). 2010 Nov;152(11):1859-71
pubmed: 20589400
Comput Cardiol. 2009;36(5445351):541-544
pubmed: 20842209
Comput Cardiol. 2008;35(4749126):653-656
pubmed: 21179377
Acta Neurochir Suppl. 2012;114:45-9
pubmed: 22327663
Am J Respir Crit Care Med. 2013 Jun 1;187(11):1157-60
pubmed: 23725609
Crit Care. 2015 Mar 16;19:118
pubmed: 25886756
Curr Opin Crit Care. 2015 Oct;21(5):467-72
pubmed: 26348424
Control Clin Trials. 1989 Mar;10(1):1-10
pubmed: 2702835
J Neurosurg Anesthesiol. 1994 Jan;6(1):4-14
pubmed: 8298263